Gist

PATHWAY is a support programme for patients taking Glivec^® (imatinib) for GIST

Gastrointestinal Stromal Tumours (GIST) is a type of cancer of the stomach and bowels. This cancer affects the tissue that surrounds the stomach and bowels and the cells grow uncontrollably.

PATHWAY was designed to provide information and support for people taking Glivec^® (imatinib) for GIST, as well as their relatives and caregivers.

PATHWAY supports you at each stage of your treatment, so whether you have just been diagnosed or have been on treatment for many years, there are tailored services and updates that you may benefit from.

If you are being treated for GIST, registering for PATHWAY will give you access to information that is relevant to you and your condition. You can also receive practical support from a PATHWAY Pharmacist who can provide information on the management of GIST as well as access to other services.

PATHWAY provides valuable support that is relevant to your needs.

The PATHWAY support programme provides you with useful information and resources that may be relevant to your individual treatment journey.

Register here to access PATHWAY support^* including:

• A personalised welcome kit in the post
• Access to fact-sheets, tips and frequently asked questions about Glivec^® (imatinib)
• Contact with a PATHWAY Nurse

The PATHWAY support programme is not authorised or approved by the Australian regulator of medicines, the Therapeutic Goods Administration. For further information, talk to your doctor. The information provided on this site should be discussed with your healthcare professional and does not replace their advice.

^*The viability of this support programme will be reviewed regularly. It could be available for a limited time.